Abbisko Therapeutics discovers and develops small‑molecule precision‑oncology and immuno‑oncology drugs that target validated oncogenic drivers and immune pathways, such as CSF‑1R, FGFR4, KRAS G12D, EGFR C797S, PD‑L1 and CXCR4. Leveraging an in‑house multi‑dimensional R&D platform that integrates cancer genomics, medicinal chemistry and biomarker science, the company advances a pipeline of over ten oral candidates, with several in clinical stages, through monotherapy and combination trials for solid tumors and rare diseases in China and globally.

AgiBot develops and manufactures humanoid robots and embodied intelligence systems designed for various applications, including interactive services and flexible manufacturing. Their technology enhances productivity by automating tasks in diverse environments, addressing labor shortages and operational inefficiencies.

Baca is an Indonesian content platform that aggregates up-to-date news, video clips, and humor in one mobile‑optimized site. It curates articles and media from multiple sources, organizes them into clear categories, and offers real‑time updates, search, and social sharing so users can stay informed and entertained without navigating separate websites.

Guangdong Shi Robot provides a cold chain cloud factory platform that utilizes artificial intelligence for supply chain management. The platform enhances temperature-controlled logistics efficiency, ensuring the safe transport of perishable goods while minimizing waste and operational costs.

Monoxer provides a cloud‑based product information management (PIM) platform that centralizes catalog data, images, and pricing for SMB retailers and brand owners. It enables bulk import, enrichment, and automated synchronization of product information across e‑commerce sites, marketplaces, and POS systems, while offering role‑based access, audit logs, and real‑time analytics to reduce manual errors and speed time‑to‑market.

Shargetech develops and manufactures gallium nitride (GaN) chargers that provide faster charging times and improved energy efficiency for consumer electronics. By utilizing GaN technology, these chargers reduce heat generation and size, addressing the demand for compact and high-performance charging solutions.

The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.